Particularly, PI3K/AKT signaling is one of the most frequently and aberrantly regulated pathways in human cancer [54,112-114], and Evi1-mediated AKT activation has been demonstrated in colon cancer cells [109]. This evidence concerns the gene RUNX1 and colonic neoplasm.